Clearpoint Neuro Inc (CLPT) 13F Investor Activity Report (Q2 2026)

CLPT ranks #3945 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

CLPT is a top-conviction position for Lane Generational LLC — at 7.0% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in CLPT belongs to BlackRock, Inc., but the position matters far more to Lane Generational LLC, who has 7.0% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Quantinno Capital Management LP has added to its CLPT position for two straight quarters, increasing it by $1.3M to reach $1.4M today.

Massar Capital Management, LP has trimmed its CLPT position for two straight quarters, cutting it by $1.5M while still holding $897.0K.

CLPT is down 4% today, but institutions show net buying of $29.1M this quarter — a divergence between today's price move and the underlying institutional flow.

CLPT reported a net loss of $34.6M over the trailing twelve months.

• Not yet profitable — net loss of $34.6M over the trailing twelve months
• Revenue grew 25.9% year over year
• Net income declined year over year, from -$22.2M to -$34.6M
• Operating cash flow was negative, using $23.9M in cash
• Current ratio of 5.91x — enough short-term assets to cover short-term liabilities
• Liabilities run 2.49x equity — a highly leveraged balance sheet worth noting